Australian (ASX) Stock Market Forum

EMD - Emyria Limited

Jump to new
System

System

Joined
27 June 2010
Posts
4,147
Reactions
309
Emerald Clinics Limited is an Australian incorporated company that operates a network of specialist medical clinics and uses purpose-built software and technology to gather high quality clinical data from informed and consenting patients.

Emerald is a clinical services and healthcare technology company focussed on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines. In addition, Emerald uses technology to capture clinical data that can be used to generate clinical evidence relating to the safety and efficacy of cannabinoid-based medicines.

Emerald has established four medical centres in Australia including one site each in West Leederville WA, Woolloomooloo NSW, Tintenbar NSW and Richmond VIC. Additional Clinics are planned across Australia within the next 12 months. Emerald is also considering the viability of expanding its operations to the United Kingdom.

It is anticipated that EMD will list on the ASX during January 2020.

https://www.emeraldclinics.com.au
 
plenty of ways to lose money

EMD listed at 20c two months ago, and hasn't gone near it since.
upload_2020-4-14_10-43-2.png
 
"Following a surge of investment and interest in the Australian cannabis market, another Australian billionaire has tipped money into the space.

Australian mining billionaire Andrew Forrest is following fellow magnate Gina Rinehart into the medical cannabis sector with a $5 million share placement into Perth-based health technology company Emyria, amid rapid growth in the sector in Australia.

It follows a surge in interest in the Australian sector worth $56.9 million as of 2020.
The investment through the family’s investing arm Tattarang comes months after Rinehart’s foray into the space with a $15 million push to support the European expansion of Western Australia-based Little Green Pharma.

Emyria has been developing trials of a synthetic cannabinoid targeting mental health, which it hopes to register domestically with the Therapeutic Goods Administration (TGA) as well as in the American market. "
www.businessinsider.com.au

Andrew Forrest is the latest Australian billionaire to enter the medical cannabis arena with a $5 million investment

Andrew Forrest is the latest Australian billionaire to enter the medical cannabis arena with a $5 million investment in an Aussie company.
www.businessinsider.com.au www.businessinsider.com.au

big (7).gif
 
themarketonline.com.au

Emyria hits milestone in PTSD treatment with first female specialist for MDMA therapy

Emyria has nominated its first female psychiatrist to treat post-traumatic stress disorder using the drug ecstasy.
themarketonline.com.au themarketonline.com.au
05 April 2024 09:58(AEDT) Australian mental health-focused pharmaceutical company Emyria Limited (ASX: EMD) has progressed further along its pathway to securing treatment for post-traumatic stress disorder (PTSD), with the nomination of its first female psychiatrist as ‘authorised’ to treat the condition with the drug MDMA.
 
Top